adding ribociclib to endocrine therapy shows an improvement in invasive dfs in hr /her2 bc patients
Published 1 year ago • 531 plays • Length 3:08Download video MP4
Download video MP3
Similar videos
-
2:00
ribociclib in early breast cancer | nejm
-
4:11
ribociclib plus endocrine therapy improves survival in premenopausal patients with metastatic br...
-
1:39
frontline endocrine therapies and ribociclib in early stage hr her2- breast cancer
-
13:54
overall survival results from monaleesa-2: endocrine therapy and ribociclib in hr positive and h...
-
8:52
hr–positive advanced breast cancer: ribociclib improved pfs for pre and perimenopausal women
-
1:41
adapt trial: endocrine ribociclib vs. chemotherapy in hr /her2- early breast cancer
-
7:00
ribociclib and endocrine therapy improves survival for pre-menopausal women with advanced breast...
-
2:43
adaptcycle: adjuvant personalised therapy comparing endocrine therapy plus ribociclib versus che...
-
3:40
monaleesa-7: results from phase iii trial looking at ribociclib as an addition to endocrine ther...
-
3:09
overall survival results from monaleesa-3 study on ribociclib plus fulvestrant in advanced breas...
-
29:10
adjuvant abemaciclib/ribociclib #monarche/natalee #best treatment for breast cancer #cdk 4/6 -cure
-
2:23
natalee: ribociclib nsai as adjuvant treatment in patients with hr /her2− early breast cancer
-
0:36
maintenance w/ et ribociclib after 1l chemotherapy in hr /her2- metastatic breast cancer
-
0:59
ribociclib in adjuvant hr breast cancer
-
6:44
cdk4/6 inhibitor ribociclib plus fulvestrant improves overall survival in postmenopausal hr-posi...
-
8:55
researcher comment: ribociclib efficacy for visceral metastases | denise yardley
-
4:38
monarch 2: overall survival results from abermaciclib plus fulvestrant in hr her2- advanced bre...
-
3:11
a correlative analysis of coralleen: preoperative ribociclib letrozole vs chemo in hr /her2- bc
-
7:15
asco 2023 expert report in hr positive, her2 negative breast cancer by catherine harper-wynne